Drug Interactions between baloxavir marboxil and Copper
This report displays the potential drug interactions for the following 2 drugs:
- baloxavir marboxil
- Copper (copper gluconate)
Interactions between your drugs
copper gluconate baloxavir marboxil
Applies to: Copper (copper gluconate) and baloxavir marboxil
Baloxavir marboxil should not be taken together with copper gluconate. Products that contain magnesium, aluminum, calcium, iron, and/or other minerals may interfere with the absorption of baloxavir marboxil and reduce its effectiveness. Talk to your doctor or pharmacist if you have questions on how to take baloxavir marboxil or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food/lifestyle interactions
baloxavir marboxil food/lifestyle
Applies to: baloxavir marboxil
Baloxavir marboxil may be taken with or without food. However, it should not be taken with dairy products, calcium-fortified beverages, or laxatives, antacids or oral supplements that contain minerals like aluminum, calcium, iron, magnesium, selenium, and zinc. Doing so may interfere with the absorption of baloxavir marboxil and reduce its effectiveness. Talk to your doctor or pharmacist if you have questions on how to take baloxavir marboxil or other medications you are prescribed.
Disease interactions
copper gluconate Biliary Obstruction
Applies to: Biliary Obstruction
The trace elements, copper and manganese, are excreted in the bile. Copper and manganese doses may need to be adjusted, reduced, or omitted in patients with liver disease or biliary obstruction.
copper gluconate Liver Disease
Applies to: Liver Disease
The trace elements, copper and manganese, are excreted in the bile. Copper and manganese doses may need to be adjusted, reduced, or omitted in patients with liver disease or biliary obstruction.
copper gluconate Malabsorption Syndrome
Applies to: Malabsorption Syndrome
The trace metals manganese, chromium, copper, selenium, and zinc are absorbed in the GI tract from dietary sources and following administration of oral supplements. GI absorption may be decreased in patients with malabsorption syndromes. Therefore, larger dosages may be required when these supplements are given orally. Parenteral administration may be appropriate.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.